NCT04634942

A Comparison of Two Different Methods to Reduce Intramusculer Injection Pain

Completed NA Last updated 18 November 2020

What this trial tests

NA trial testing Cryos REF 0971 Cold Spray in Healthy in 195 participants. Completed in 15 August 2020.

Timeline

25 February 2010

Primary endpoint
11 July 2020

15 August 2020

Quick facts

Lead sponsor	Inonu University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	195
Start date	25 February 2010
Primary completion	11 July 2020
Estimated completion	15 August 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• Cryos REF 0971 Cold Spray
• ShotBlocker BIONIX Press Firmly USA

Conditions studied

• Healthy — all drugs for Healthy →

Sponsor

Inonu University

Who can join

18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

When the literature is reviewed, there are few studies evaluating cold spray or ShotBlocker in reducing pain associated with IM injection. Studies have shown that these applications are mostly used in children during vaccination or intravenous interventions. These methods are less commonly used on adults. Both methods without side effects are important in terms of being cheap, easy to use and reusable. As a result of the researches, these methods can provide a more comfortable injection experience and provide evidence for pain management, especially in adults sensitive to pain.

The aim of the study is to use it to reduce pain associated with IM injection in adults.

To evaluate the effect of cold spray and ShotBlocker applications on pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.